Nykode Therapeutics AS (STU:5VB) Other Income (Expense) : €-3.76 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Other Income (Expense)?

Nykode Therapeutics AS's other income expense for the Nykode Therapeutics AS's pretax income for the three months ended in Dec. 2024 was €-2.19 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-3.76 Mil.

Nykode Therapeutics AS Other Income (Expense) Historical Data

The historical data trend for Nykode Therapeutics AS's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Other Income (Expense) Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

2.22

-0.45

-1.07

4.84

-3.82

Nykode Therapeutics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															4.62	-2.56	0.70	0.29	-2.19

Nykode Therapeutics AS Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.76 Mil.

Nykode Therapeutics AS (STU:5VB) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (STU:5VB) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

VACBF:USA NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.

Nykode Therapeutics AS Headlines

No Headlines